Your browser doesn't support javascript.
loading
Design and applications of modified oligonucleotides
Gallo, M; Montserrat, J. M; Iribarren, A. M.
  • Gallo, M; Universidad de Buenos Aires. Consejo de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular. Laboratorio de Química de Acidos Nucleicos. Buenos Aires. AR
  • Montserrat, J. M; Universidad de Buenos Aires. Consejo de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular. Laboratorio de Química de Acidos Nucleicos. Buenos Aires. AR
  • Iribarren, A. M; Universidad de Buenos Aires. Consejo de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular. Laboratorio de Química de Acidos Nucleicos. Buenos Aires. AR
Braz. j. med. biol. res ; 36(2): 143-151, Feb. 2003. ilus
Article in English | LILACS | ID: lil-326425
RESUMO
Oligonucleotides have a wide range of applications in fields such as biotechnology, molecular biology, diagnosis and therapy. However, the spectrum of uses can be broadened by introducing chemical modifications into their structures. The most prolific field in the search for new oligonucleotide analogs is the antisense strategy, where chemical modifications confer appropriate characteristics such as hybridization, resistance to nucleases, cellular uptake, selectivity and, basically, good pharmacokinetic and pharmacodynamic properties. Combinatorial technology is another research area where oligonucleotides and their analogs are extensively employed. Aptamers, new catalytic ribozymes and deoxyribozymes are RNA or DNA molecules individualized from a randomly synthesized library on the basis of a particular property. They are identified by repeated cycles of selection and amplification, using PCR technologies. Modified nucleotides can be introduced either during the amplification procedure or after selection
Subject(s)
Full text: Available Index: LILACS (Americas) Main subject: Oligonucleotides / Drug Design Type of study: Prognostic study Limits: Humans Language: English Journal: Braz. j. med. biol. res Journal subject: Biology / Medicine Year: 2003 Type: Article / Congress and conference Affiliation country: Argentina Institution/Affiliation country: Universidad de Buenos Aires/AR

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Oligonucleotides / Drug Design Type of study: Prognostic study Limits: Humans Language: English Journal: Braz. j. med. biol. res Journal subject: Biology / Medicine Year: 2003 Type: Article / Congress and conference Affiliation country: Argentina Institution/Affiliation country: Universidad de Buenos Aires/AR